← Back to dossier
Patient handout

Acute Mesenteric Ischemia

PRODUCTION

1. Your condition

This handout is for acute mesenteric ischemia. Your care team identified this based on: severe abdominal pain out of proportion to exam findings (wses 2017 hallmark).

Other reasons your team may use this plan: sudden severe periumbilical pain with vomiting / diarrhea (sma embolism); atrial fibrillation, recent mi, or known atherosclerosis with new abdominal pain (embolic source); unexplained lactic acidosis + abdominal pain (late finding, transmural infarction).

2. Your medications

Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.

MedicationStarting doseHowWhenWhat it does
heparin80 U/kg IV bolus then 18 U/kg/h infusion titrated to aPTT 1.5-2.5x control (or anti-Xa 0.3-0.7)IVcontinuousWSES 2017 — IV UFH first-line for all AMI etiologies; preferred over LMWH due to titrability and potential need for emergent surgery
crystalloid_resuscitationBalanced crystalloid 20-30 mL/kg IV titrated to MAP ≥65 and UOP ≥0.5 mL/kg/hIVcontinuousWSES 2017 — restore perfusion; avoid excessive saline (worsens acidosis)

Plan: Acute mesenteric ischemia — etiology-driven anticoagulation + revascularization + sepsis support (WSES 2017)

4. When to seek emergency care

Call 911 or go to the nearest emergency room right away if you have:

  • Peritoneal signs (rigidity, rebound, guarding) on exam = transmural bowel infarction (WSES 2017)(life-threatening)
  • CT shows pneumatosis intestinalis or portal venous gas = bowel necrosis (WSES 2017)(life-threatening)
  • Lactate >4 mmol/L AND rising despite resuscitation = ongoing bowel infarction (WSES 2017)(life-threatening)
  • NOMI confirmed on CTA — diffuse vasoconstriction without occlusion in a critically ill / low-flow patient (WSES 2017)
  • MVT on CTA without arterial involvement, no peritoneal signs (WSES 2017)

5. Follow-up

Long-term anticoagulation per etiology (MVT lifelong if unprovoked / thrombophilia; arterial per source); short-bowel syndrome management if extensive resection; nutrition support; secondary prevention (statin, antiplatelet, AF anticoagulation) (WSES 2017)

6. Sources

Guideline: WSES 2017 Acute Mesenteric Ischaemia Guidelines (Bala et al, World J Emerg Surg 2017)

  1. pubmed.ncbi.nlm.nih.gov/28794797